Breaking News Instant updates and real-time market news.

LBTYA

Liberty Global

$21.39 /

+0.37 (+1.76%)

20:52
01/15/20
01/15
20:52
01/15/20
20:52

Liberty Global reinstated with a Neutral at Goldman Sachs

Goldman Sachs analyst Michael Bishop reinstated coverage of Liberty Global with a Neutral rating and $24 price target. The analyst sees the outlook for the company as challenging in 2020 and believes that it will see continued operating cash flow declines of 2.4% given the headwinds it is facing in the U.K. and in Switzerland. Bishop adds however that Liberty Global is retaining "significant M&A optionality" which could be free-cash-flow accretive and models about $1B in incremental annual buybacks for the company.

  • 14

    Feb

LBTYA Liberty Global
$21.39 /

+0.37 (+1.76%)

01/08/20 Citi
Liberty Global price target lowered to $21 from $25 at Citi
11/18/19 Barclays
Liberty Global downgraded to Underweight from Equal Weight at Barclays
10/23/19 Benchmark
Liberty Global price target lowered to $32 from $34 at Benchmark
10/17/19 HSBC
Liberty Global downgraded to Hold at HSBC

TODAY'S FREE FLY STORIES

Hot Stocks
MapKure, SpringsWorks, BeiGene initiate Phase 1 trial of BGB-3245 » 08:00
02/27/20
02/27
08:00
02/27/20
08:00
SWTX

SpringsWorks Therapeutics

$31.49 /

+0.475 (+1.53%)

, BGNE

BeiGene

$158.03 /

-0.42 (-0.27%)

MapKure, together with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Gilead call buyer realizes 56% same-day gains » 08:00
02/27/20
02/27
08:00
02/27/20
08:00
GILD

Gilead

$74.70 /

+4.57 (+6.52%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Heico selloff overdone, raised to Fresh Pick at Baird » 08:00
02/27/20
02/27
08:00
02/27/20
08:00
HEI

Heico

$103.45 /

-9.86 (-8.70%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD » 08:00
02/27/20
02/27
08:00
02/27/20
08:00

FX Action: USD-CAD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Alpha Pro Tech books approx. $14.1M orders for N-95 face mask » 07:57
02/27/20
02/27
07:57
02/27/20
07:57
APT

Alpha Pro Tech

$12.41 /

+2.5 (+25.23%)

Alpha Pro Tech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Carvana price target raised to $100 from $87 at Baird » 07:57
02/27/20
02/27
07:57
02/27/20
07:57
CVNA

Carvana

$101.66 /

-2.535 (-2.43%)

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
uniQure presents new preclinical data on AMT-130 » 07:55
02/27/20
02/27
07:55
02/27/20
07:55
QURE

uniQure

$53.57 /

-0.96 (-1.76%)

uniQure announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Aqua America to host investor day » 07:55
02/27/20
02/27
07:55
02/27/20
07:55
WTR

Aqua America

$0.00 /

+ (+0.00%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Crane to host investor day » 07:55
02/27/20
02/27
07:55
02/27/20
07:55
CR

Crane

$74.85 /

-2.39 (-3.09%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Teladoc price target raised to $130 from $100 at Baird » 07:54
02/27/20
02/27
07:54
02/27/20
07:54
TDOC

Teladoc

$116.89 /

-1.55 (-1.31%)

Baird analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Athenex provides outlook on upcoming milestones » 07:53
02/27/20
02/27
07:53
02/27/20
07:53
ATNX

Athenex

$12.26 /

-0.11 (-0.89%)

Outlook and Upcoming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Athenex expects cash, cash equivalents to fund operations into 1Q21 » 07:52
02/27/20
02/27
07:52
02/27/20
07:52
ATNX

Athenex

$12.26 /

-0.11 (-0.89%)

At December 31, 2019, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Upwork sees Q1 revenue $81.5M-$82.5M, consensus $83.46M » 07:51
02/27/20
02/27
07:51
02/27/20
07:51
UPWK

Upwork

$8.13 /

-0.19 (-2.28%)

In yesterday's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anaplan sinks 26%, or $15.9, to $42.80 following Q4 results  07:51
02/27/20
02/27
07:51
02/27/20
07:51
PLAN

Anaplan

$57.97 /

+0.87 (+1.52%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anaplan Chief Growth Officer Mark Anderson stepping down » 07:51
02/27/20
02/27
07:51
02/27/20
07:51
PLAN

Anaplan

$57.97 /

+0.87 (+1.52%)

Anaplan announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Esperion expects U.S. commercial launch of NEXLETOL March 30 » 07:51
02/27/20
02/27
07:51
02/27/20
07:51
ESPR

Esperion

$57.06 /

-2.91 (-4.85%)

Three data presentations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Esperion expects potential ROW development in April » 07:50
02/27/20
02/27
07:50
02/27/20
07:50
ESPR

Esperion

$57.06 /

-2.91 (-4.85%)

European Commission…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
TJX price target raised to $75 from $70 at Guggenheim » 07:50
02/27/20
02/27
07:50
02/27/20
07:50
TJX

TJX

$64.05 /

+4.28 (+7.16%)

, ROST

Ross Stores

$119.24 /

+2.52 (+2.16%)

, BURL

Burlington Stores

$234.06 /

-1.305 (-0.55%)

Guggenheim analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Etsy price target raised to $75 from $70 at Loop Capital » 07:50
02/27/20
02/27
07:50
02/27/20
07:50
ETSY

Etsy

$50.64 /

+0.73 (+1.46%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Esperion expects U.S. commercial launch of NEXLIZET in July » 07:49
02/27/20
02/27
07:49
02/27/20
07:49
ESPR

Esperion

$57.06 /

-2.91 (-4.85%)

Sees $150M milestone…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Esperion sees cash sufficient to fund operations through profitability » 07:48
02/27/20
02/27
07:48
02/27/20
07:48
ESPR

Esperion

$57.06 /

-2.91 (-4.85%)

Esperion expects $175…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Nexstar price target raised to $150 from $142 at Guggenheim » 07:47
02/27/20
02/27
07:47
02/27/20
07:47
NXST

Nexstar

$107.14 /

-6.79 (-5.96%)

Guggenheim analyst Curry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Credit Suisse anticipates quick recovery for Microsoft given strong end demand » 07:46
02/27/20
02/27
07:46
02/27/20
07:46
MSFT

Microsoft

$170.20 /

+2.14 (+1.27%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BioLineRx granted patent by USPTO for Motixafortide » 07:46
02/27/20
02/27
07:46
02/27/20
07:46
BLRX

BioLineRx

$1.78 /

-0.11 (-5.82%)

BioLineRx announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Emcor sees FY20 EPS $5.60-$6.30, consensus $6.00 » 07:46
02/27/20
02/27
07:46
02/27/20
07:46
EME

Emcor

$79.42 /

-1.2 (-1.49%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.